Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Operating Expenses (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Operating Expenses data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Operating Expenses rose 21.68% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $8.3 million, down 14.11%, while the annual FY2024 figure was $8.6 million, 25.29% down from the prior year.
  • Operating Expenses reached $3.0 million in Q3 2025 per UTMD's latest filing, up from $2.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.4 million in Q1 2023 and bottomed at $491000.0 in Q4 2024.
  • Average Operating Expenses over 5 years is $2.6 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: tumbled 66.58% in 2024, then rose 21.68% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $1.6 million in 2021, then rose by 11.54% to $1.8 million in 2022, then decreased by 16.06% to $1.5 million in 2023, then crashed by 66.58% to $491000.0 in 2024, then skyrocketed by 509.37% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $3.0 million in Q3 2025, $2.4 million in Q2 2025, and $2.4 million in Q1 2025.